Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2001-7-23
pubmed:abstractText
Immunostimulatory DNA sequences (ISS, also known as CpG motifs) are pathogen-associated molecular patterns that are potent stimulators of innate immunity. We tested the ability of ISS to act as an immunostimulatory pathogen-associated molecular pattern in a model HIV vaccine using gp120 envelope protein as the Ag. Mice immunized with gp120 and ISS, or a gp120:ISS conjugate, developed gp120-specific immune responses which included: 1) Ab production; 2) a Th1-biased cytokine response; 3) the secretion of beta-chemokines, which are known to inhibit the use of the CCR5 coreceptor by HIV; 4) CTL activity; 5) mucosal immune responses; and 6) CD8 T cell responses that were independent of CD4 T cell help. Based on these results, ISS-based immunization holds promise for the development of an effective preventive and therapeutic HIV vaccine.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/AIDS Vaccines, http://linkedlifedata.com/resource/pubmed/chemical/Adjuvants, Immunologic, http://linkedlifedata.com/resource/pubmed/chemical/Anti-HIV Agents, http://linkedlifedata.com/resource/pubmed/chemical/CPG-oligonucleotide, http://linkedlifedata.com/resource/pubmed/chemical/Chemokines, http://linkedlifedata.com/resource/pubmed/chemical/Cytokines, http://linkedlifedata.com/resource/pubmed/chemical/H-2 Antigens, http://linkedlifedata.com/resource/pubmed/chemical/H-2K(K) antigen, http://linkedlifedata.com/resource/pubmed/chemical/HIV Envelope Protein gp120, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin A, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G, http://linkedlifedata.com/resource/pubmed/chemical/Oligodeoxyribonucleotides, http://linkedlifedata.com/resource/pubmed/chemical/Vaccines, DNA
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
167
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1584-91
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:11466380-AIDS Vaccines, pubmed-meshheading:11466380-Adjuvants, Immunologic, pubmed-meshheading:11466380-Administration, Intranasal, pubmed-meshheading:11466380-Animals, pubmed-meshheading:11466380-Anti-HIV Agents, pubmed-meshheading:11466380-Chemokines, pubmed-meshheading:11466380-CpG Islands, pubmed-meshheading:11466380-Cytokines, pubmed-meshheading:11466380-Cytotoxicity, Immunologic, pubmed-meshheading:11466380-Female, pubmed-meshheading:11466380-H-2 Antigens, pubmed-meshheading:11466380-HIV Envelope Protein gp120, pubmed-meshheading:11466380-Immunity, Mucosal, pubmed-meshheading:11466380-Immunoglobulin A, pubmed-meshheading:11466380-Immunoglobulin G, pubmed-meshheading:11466380-Lymphocyte Activation, pubmed-meshheading:11466380-Mice, pubmed-meshheading:11466380-Mice, Inbred BALB C, pubmed-meshheading:11466380-Oligodeoxyribonucleotides, pubmed-meshheading:11466380-T-Lymphocytes, Cytotoxic, pubmed-meshheading:11466380-Th1 Cells, pubmed-meshheading:11466380-Vaccines, DNA
pubmed:year
2001
pubmed:articleTitle
Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites.
pubmed:affiliation
Department of Medicine, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't